Showing results 1 to 20 of 59
next >
| Rights | Preview | Issue Date | Title | Author(s) | Type |
| closedAccess |  | Mar-2021 | 6q deletion in Waldenström macroglobulinaemia negatively affects time to transformation and survival | García-Sanz, Ramón; Dogliotti, Irene; Zaccaria, Gian Maria; Ocio, Enrique M. CSIC ORCID ; Rubio, Araceli; Murillo, Ilda; Escalante, Fernando; Aguilera, Carmen; García-Mateo, Aránzazu; García de Coca, Alfonso; Hernández, Roberto; Dávila, Julio; Puig, Noemi; García-Alvarez, María; Chillón, M. del Carmen; Alcoceba, Miguel; Medina, Alejandro; González-Calle, Verónica; Sarasquete, María Eugenia; González, Marcos CSIC ORCID ; Gutiérrez, Norma Carmen; Jiménez, Cristina CSIC | artículo |
| closedAccess |  | 2013 | A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control | Paiva, Bruno; Vidriales, Maria Belén; Martínez-López, Joaquín; Mateos, Maria Victoria; Ocio, Enrique M. CSIC ORCID ; Gutiérrez, Norma Carmen; Díaz-Mediavilla, J.; Orfao, Alberto CSIC ORCID ; Lahuerta, Juan José; Bladé, Joan; San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess |  | 2017 | Absence of spontaneous response improvement beyond day +100 after autologous stem cell transplantation in multiple myeloma | Fernández de Larrea, Carlos; Dávila, Julio; Isola, I.; Ocio, Enrique M. CSIC ORCID ; Rosiñol, Laura; García-Sanz, Ramón; Cibeira, M.T.; Tovar, N.; Rovira, M.; Mateos, Maria Victoria; Miguel, J. S.; Bladé, Joan | artículo |
| closedAccess |  | 2017 | Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma | Rojas, Elizabeta A.; Corchete, Luis A.; San-Segundo, Laura; Martínez-Blanch, Juan F.; Codoñer, Francisco M.; Paíno, Teresa CSIC ORCID; Puig, Noemi; García-Sanz, Ramón; Mateos, Maria Victoria; Ocio, Enrique M. CSIC ORCID ; Misiewicz-Krzeminska, Irena; Gutiérrez, Norma Carmen | artículo |
| openAccess |  | 2013 | Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry | Pessoa de Magalhães, Roberto J.; Vidriales, Maria Belén; Paiva, Bruno; Fernández, Carlos; García-Sanz, Ramón; Mateos, Maria Victoria; Gutiérrez, Norma Carmen; Lécrevisse, Quentin; Blanco, Juan F.; Martínez-López, Joaquín; Sobral da Costa, E.; Ocio, Enrique M. CSIC ORCID ; Pérez-Andrés, Martin; Lahuerta, Juan José; San Miguel, Jesús F. CSIC ORCID; Orfao, Alberto CSIC ORCID | artículo |
| closedAccess |  | 2008 | Aplidin, a marine organism-derived compound with potent antimyeloma activity in vitro and in vivo | Mitsiades, C. S.; Ocio, Enrique M. CSIC ORCID ; Pandiella, Atanasio CSIC ORCID CVN ; Maiso, Patricia; Gajate, Consuelo CSIC ORCID ; Garayoa, Mercedes CSIC ORCID ; Vilanova, David; Montero, Juan Carlos CSIC ORCID; Mollinedo, Faustino CSIC ORCID ; San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess |  | 2011 | BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients | Visani, Giuseppe; Ocio, Enrique M. CSIC ORCID ; Caballero, Maria Dolores | artículo |
| openAccess |  | 2012 | CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype | Paíno, Teresa CSIC ORCID; Ocio, Enrique M. CSIC ORCID ; Paiva, Bruno; San-Segundo, Laura; Garayoa, Mercedes CSIC ORCID ; Gutiérrez, Norma Carmen; Sarasquete, María Eugenia; Pandiella, Atanasio CSIC ORCID CVN ; Orfao, Alberto CSIC ORCID ; San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess |  | 2018 | Cereblon gene expression and correlation with clinical outcomes in patients with relapsed/refractory multiple myeloma treated with pomalidomide: an analysis of STRATUS | Qian, Xiaozhong; Dimopoulos, Meletios A.; Amateangelo, Michael; Bjorklund, Chad; Towfic, Fadi; Flynt, Erin; Weisel, Katja C.; Ocio, Enrique M. CSIC ORCID ; Peluso, Teresa; Sternas, Lars; Zaki, Mohamed H.; Moreau, Philippe; Thakurta, Anjan | artículo |
| closedAccess |  | 2018 | Changes in the gene expression profile of multiple myeloma cell line in response to immunomodulatory (IMIDs) drugs: MYB gen target | Fernández-Lázaro, Diego; Fernández-Lázaro, César Ignacio; San-Segundo, Laura; Ocio, Enrique M. CSIC ORCID | comunicación de congreso |
| openAccess |  | 2012 | Dasatinib as a bone-modifying agent: Anabolic and anti-resorptive effects | García-Gómez, Antonio; Ocio, Enrique M. CSIC ORCID ; Crusoe, Edvan; Santamaría, Carlos; Hernández-Campo, Pilar M.; Blanco, Juan F.; Sánchez-Guijo, Fermín M.; Hernández, M. Teresa CSIC; Briñón, Jesús G.; Pandiella, Atanasio CSIC ORCID CVN ; San Miguel, Jesús F. CSIC ORCID; Garayoa, Mercedes CSIC ORCID | artículo |
| closedAccess |  | 2018 | Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role | Rodríguez-Otero, Paula; Mateos, Maria Victoria; Martínez-López, Joaquín; Martín-Calvo, Nerea; Hernandez, Miguel T.; Ocio, Enrique M. CSIC ORCID ; Rosiñol, Laura; Martínez, Rafael; Teruel, Ana-Isabel; Gutiérrez, Norma Carmen; Bargay, Joan; Bengoechea, Óscar; Gonzalez, Yolanda; Pérez de Oteyza, Jaime; Gironella, Mercedes; Encinas, Cristina; Martín, Jesús; Cabrera, Carmen; Palomera, Luis; Arriba, Felipe de; Cedena, Maria-Teresa; Paiva, Bruno; Puig, Noemi; Oriol, Albert; Bladé, Joan; Lahuerta, Juan José; Miguel, Jesus F. San | artículo |
| closedAccess |  | 2015 | Evidence of long-term disease control with panobinostat maintenance in patients with relapsed multiple myeloma | Ocio, Enrique M. CSIC ORCID ; Dávila, Julio; Caballero, Juan-Carlos; Alonso-Álvarez, Sara; González-Calle, Verónica; García-Sanz, Ramón; San Miguel, Jesús F. CSIC ORCID; Mateos, Maria Victoria | artículo |
| closedAccess |  | 2020 | Filanesib for the treatment of multiple myeloma | Algarín, Esperanza M.; Hernández-García, Susana; Garayoa, Mercedes CSIC ORCID ; Ocio, Enrique M. CSIC ORCID | artículo |
| closedAccess |  | 2020 | Filanesib in combination with pomalidomide and dexamethasone in refractory MM patients: safety and efficacy, and association with alpha 1‐acid glycoprotein (AAG) levels. Phase Ib/II Pomdefil clinical trial conducted by the Spanish MM group | Ocio, Enrique M. CSIC ORCID ; Motlló, Cristina; Rodríguez-Otero, Paula; Martínez-López, Joaquín; Cejalvo, Mª José; Martín-Sánchez, Jesús; Bladé, Joan; García‐Malo, Mª Dolores; Dourdil, Mª Victoria; García-Mateo, Aránzazu; Arriba, Felipe de; García-Sanz, Ramón; Rubia, Javier de la; Oriol, Albert; Lahuerta, Juan José; San Miguel, Jesús F. CSIC ORCID; Mateos, Maria Victoria | artículo |
| closedAccess |  | 2019 | Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis | Puig, Noemi; Paiva, Bruno; Lasa, Marta; Burgos, Leire; Pérez, José J.; Merino, Juana; Moreno, Cristina; Vidriales, Maria Belén; Gómez Toboso, Dolores; Cedena, Maria-Teresa; Ocio, Enrique M. CSIC ORCID ; Lécumberri, Ramon; García de Coca, Alfonso; Labrador, Jorge; Gonzalez, Maria-Esther; Palomera, Luis; Gironella, Mercedes; Cabañas, Valentin; Casanova, María; Oriol, Albert; Krsnik, Isabel; Pérez-Montaña, Albert; Rubia, Javier de la; Puerta, Jose-Enrique de la; Arriba, Felipe de; Prosper, Felipe; Martínez-López, Joaquín; Lécrevisse, Quentin; Verde, Javier; Mateos, Maria Victoria; Lahuerta, Juan José; Orfao, Alberto CSIC ORCID ; San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess |  | 2014 | Genetic and pharmacologic evidence that mTOR targeting outweighs mTORC1 Inhibition as an antimyeloma strategy | Chen, Xi CSIC; Díaz-Rodríguez, Elena CSIC ORCID CVN; Ocio, Enrique M. CSIC ORCID ; Paiva, Bruno; San Miguel, Jesús F. CSIC ORCID; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 2020 | Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis | Cuenca, Isabel; Alameda, Daniel; Sanchez-Vega, Beatriz; Gomez-Sanchez, David; Alignani, Diego; Lasa, Marta; Onecha, Esther; Lécumberri, Ramon; Prosper, Felipe; Ocio, Enrique M. CSIC ORCID ; Gonzalez, Maria-Esther; García de Coca, Alfonso; Rubia, Javier de la; Gironella, Mercedes; Palomera, Luis; Oriol, Albert; Casanova, María; Cabañas, Valentin; Taboada, Francisco; Pérez-Montaña, Albert; Arriba, Felipe de; Puig, Noemi; Carreño-Tarragona, Gonzalo; Barrio, Santiago; Puerta, José Enrique de la; Ramirez-Payer, Angel; Krsnik, Isabel; Bargay, Joan; Lahuerta, Juan José; Mateos, Maria Victoria; San Miguel, Jesús F. CSIC ORCID; Paiva, Bruno; Martínez-López, Joaquín | artículo |
| openAccess |  | 1-May-2010 | In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma | Ocio, Enrique M. CSIC ORCID ; Vilanova, David; Maiso, Patricia; Crusoe, Edvan; Fernández-Lázaro, Diego; Garayoa, Mercedes CSIC ORCID ; San-Segundo, Laura; Hernández, M. Teresa CSIC; San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess |  | 2015 | In vivo murine model of acquired resistance in myeloma reveals differential mechanisms for lenalidomide and pomalidomide in combination with dexamethasone | Ocio, Enrique M. CSIC ORCID ; Fernández-Lázaro, Diego; San-Segundo, Laura; López-Corral, L.; Corchete, Luis A.; Gutiérrez, Norma Carmen; Garayoa, Mercedes CSIC ORCID ; Paíno, Teresa CSIC ORCID; García-Gómez, Antonio; Delgado, Manuel; Montero, Juan Carlos CSIC ORCID; Díaz-Rodríguez, Elena CSIC ORCID CVN; Mateos, Maria Victoria; Pandiella, Atanasio CSIC ORCID CVN ; San Miguel, Jesús F. CSIC ORCID | artículo |
